Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001325704 | SCV001516707 | benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820016 | SCV002064941 | likely benign | not specified | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001325704 | SCV002578645 | uncertain significance | not provided | 2023-07-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28545555) |
Ambry Genetics | RCV002546138 | SCV003758158 | likely benign | Inborn genetic diseases | 2021-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004548168 | SCV004762823 | likely benign | SAMD9-related disorder | 2020-04-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |